Rapid cycling bipolar disorder

Bibliography

• Diagnostic and Statistical Manual (IV Edition). American Psychiatric Association, Washington, USA (1994).
   Google Scholar
• DUNNER DL, FIEVE RR: Clinical factors in lithium carbonate prophylaxis failure. Arch. Gen. Psych. (1974) 30(2):229–233.
   PubMed Web of Science ®Google Scholar
• WEHR T, SACK D, ROSENTHAL N, COWDRY R: Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients. Am. I Psych. (1988) 145(2):179–184.
   Google Scholar
• KUKOPULOS A, REGINALDI D, LADDOMADA P, FLORIS G, SERRA G, TONDO L: Course of the manic-depressive cycle and changes caused by treatments. Neuropsychopharmakologie (1980) 13:156–167.
   PubMedGoogle Scholar
• TONDO L, BALDESSARINI R: Rapid cycling in women and men with bipolar manic depressive disorders. Am. I Psych. (1998) 155:1434–1436.
   PubMed Web of Science ®Google Scholar
• TURNBRIDGE W, EVERED D, HALL R et al.: The spectrum of thyroid disease in a community: the Whickham Survey. CM]. Endocritiol (1977) 7:481–493.
   Google Scholar
• WHYBROW PC, BAUER MS: Rapid cycling bipolar affective disorder. Arch. Gen. Psych. (1990) 47(5):435–440.
   Google Scholar
• GOODWIN FK, JAMISON R: Manic-Depressive Illness. Oxford University Press New York, USA (1990).
   Google Scholar
• CALABRESE JR, WOYSHVILLE MJ: A medication algorithm for treatment of bipolar rapid cycling. I Clin. Psych. (1995) 56(S3):11–18.
   Google Scholar
• CORYELL W, ENDICOTT J, KELLER M: Rapid cycling affective disorder: demographics, family history, and course. Arch. Gen. Psych. (1992) 49:126–131.
   PubMed Web of Science ®Google Scholar
• LEIBENLUFT E: Women and bipolar disorder: an update. Bull. Menninger CM]. (2000) 101(6):444–451.
   Google Scholar
• SIMPSON HB, HUROWITZ GL, LIEBOWITZ MR: General principles in the pharmacotherapy of antidepressant-induced rapid-cycling: a case series. I Clin. Psychopharmacol. (1997) 17:460–466.
   Google Scholar
• SWANN AC, BOWDEN CL, CALABRESE JR, DILSAVER SC, MORRIS DD: Mania: differential effects of previous depressive and manic episodes on response to treatment. Acta Psychiatrica Land. (2000) 101(6):444–451.
   PubMed Web of Science ®Google Scholar
• OKUMA T: Effects of carbamazepine and lithium on affective disorders. Neuropsychobiology (1993) 27:138–145.
   PubMed Web of Science ®Google Scholar
• BALLENGER JC, POST RM: Therapeutic effects of carbamazepine in affective disorder: a preliminary report. Commun. Psychopharmacol (1978) 2:159–178.
   PubMedGoogle Scholar
• JOFFE R: Carbamazepine, lithium, and life course of bipolar affective disorder. Am. J. Psych. (1991) 148:1270–1271.
   Google Scholar
• KISHIMOTO A: The treatment of affective disorder with carbamazepine: prophylactic synergism of lithium and carbamazepine combination. Prog. Neuropsychopharmacol Biol. Psych. (1992) 16:483–493.
   PubMed Web of Science ®Google Scholar
• JOYCE PR: Carbamazepine in rapid-cycling bipolar affective disorder. Int. Chu. Psychopharmacol (1988) 3:123–129.
   PubMed Web of Science ®Google Scholar
• POST RM, UHDE TW, BALLENGER JC, SQUILLACE KM: Prophylactic efficacy of carbamazepine in manic-depressive illness. Am. J. Psych. (1983) 140:1602–1604.
   PubMed Web of Science ®Google Scholar
• SACHS G, PRINTZ DJ, KAHN DA, CARPENTER D, DOCHERTY JP: The expert consensus guideline series: medication treatment of bipolar disorder 2000. Pastgrad. Med. (2000) Spec. No.:1–104
   Google Scholar
• KUSUMAKAR V, YATHAM LN, HASLAM DRS et al.: Treatment of mania, mixed state, and rapid cycling. Can. J. Psych. (1997) 42\(Suppl. 2):795–865.
   Google Scholar
• HIRSCHFELD RM, ALLEN MH, MCEVOY JP, KECK PE JR, RUSSELL JM: Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients. J. Chu. Psych. (1999) 60(12):815–818.
   Google Scholar
• CALABRESE JR, DELUCCHI GA: Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder. Am. J. Psych. (1990) 147:431–434.
   PubMed Web of Science ®Google Scholar
• CALABRESE JR, MARKOVITZ PJ, KIMMEL SE: Spectrum of efficacy of valproate in 78 rapid-cycling bipolar patients. J. Chu. Psychopharmacol (1992) 12\(Suppl. 1):535–575.
   Google Scholar
• CALABRESE JR, RAPPORT DJ, KIMMEL SE, REECE B, WOYSHVILLE MJ: Rapid cycling bipolar disorder and its treatment with valproate. Can. J. Psych. (1993) 38\(Suppl. 2):S57–S60.
   Google Scholar
• SCHAFF MR, FAWCETT J, ZAJECKA JM: Diyalproex sodium in the treatment of refractory affective disorders. J. Chu. Psych. (1993) 54:380–384.
   Google Scholar
• BOWDEN CL, JANICAK PG, ORSULAK P et al: Efficacy of divalproex vs. lithium and placebo in the treatment of mania. JAMA (1994) 271(12):918–924.
   Google Scholar
• SHARMA V, PERSAD E, MAZMANIAN D, KARUNARATNE K: Treatment of rapid-cycling bipolar disorder with combination therapy of valproate and lithium. Can. J. Psych. (1993) 54:380–384.
   Google Scholar
• MCELROY SL, KECK PE JR, POPE HG JR, HUDSON JI: Valproate in the treatment of rapid-cycling bipolar disorder. J. Chu. Psychopharmacol (1988) 8(4):275–279.
   Google Scholar
• KETTER TA, PAZZAGLIA PJ, POST RM: Synergy of carbamazepine and valproic acid in affective illness: case report and review of the literature. J. Chu. Psychopharmacol (1992) 12:276–281.
   PubMed Web of Science ®Google Scholar
• CALABRESE JR, DELLUCI GA: Phenomenology of rapid-cycling manic-depression and its treatment with valproate. J. Chu. Psych. (1989) 50\(Suppl. 3):30–40.
   Google Scholar
• SOVNER R: A clinically significant interaction between carbamazepine and valproic acid. J. Chu. Psychopharmacol (1988) 8:448–449.
   Google Scholar
• CALABRESE JR, BOWDEN CL, MCELROY SL et al.: Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder. Am. J. Psych. (1999) 156:1019–1023.
   PubMed Web of Science ®Google Scholar
• BOWDEN CL, CALABRESE JR, MCELROY etal.: The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder. Biol. Psych. (1999) 45(8):953–958.
   Google Scholar
• SPORN J, SACHS G: The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness. J. Chu. Psychopharmacol (1997) 17(3):185–189.
   Google Scholar
• CALABRESE JR, FATEMI SH, WOYSHVILLE M: Antidepressant effects of lamotrigine in rapid cycling bipolar disorder. Am. J. Psych. (1996) 153(9):1236.
   PubMed Web of Science ®Google Scholar
• KUSUMAKAR V, YATHAM L: Lamotrigine treatment of rapid cycling bipolar disorder. Am. J. Psych. (1997) 154(8):1171–1172.
   PubMedGoogle Scholar
• FATEMI SH, RAPPORT DJ, CALABRESE JR, THURAS P: Lamotrigine in rapid cycling bipolar disorder. J. Chu. Psych. (1997) 58(12):522–527.
   PubMed Web of Science ®Google Scholar
• FRYE M, KETTER T, KIMBRELL T et al.:A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J. Chu. Psychopharmacol (2000) 20(6):607–614.
   PubMed Web of Science ®Google Scholar
• CALABRESE JR, SUPPES T, BOWDEN C et al.: A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. J. Chu. Psych. (2000) 61(11):841–849.
   PubMed Web of Science ®Google Scholar
• MARCOTTE D: Use of topiramate, a newanti-epileptic as a mood stabilizer. J. Affect. Dis. (1998) 50:245–251.
   PubMed Web of Science ®Google Scholar
• KUSUMAKAR V, YATHAM LN, O'DONOVAN CA, KUTCHER SP: Topiramate in rapid-cycling bipolar women. New Research, American Psychiatric Association Annual Meeting, #NR477 Washington DC, USA (1999):200.
   Google Scholar
• KUSUMAKAR V, YATHAM LN, O'DONOVAN C, KUTCHER SP: Topiramate in the treatment of refractory ultra-rapid and ultradian cycling bipolar disorder. NCDEU Annual Meeting. Boca Raton, FL, USA (1999).
   Google Scholar
• BROWN GM, STONE GH, RATHBONE MP: Primidone and rapid cycling affective disorders. Lancet (1993) 342:925.
   Google Scholar
• SOLOMON L, WILLIAMSON P: Verapamil in bipolar illness. Can. J. Psych. (1986) 31:442–444.
   Google Scholar
• GITLIN MJ, WEISS J: Verapamil as maintenance treatment in bipolar illness: a case report. J. Chu. Psychopharmacol (1984) 4:341–343.
   PubMed Web of Science ®Google Scholar
• JACOBSEN FM, SACK DA, JAMES SP: Delirium induced by verapamil. Am. J. Psych. (1987) 144:248.
   PubMed Web of Science ®Google Scholar
• GOODNICK P: Nimodipine treatment of rapid cycling bipolar disorder. J. Chu. Psych. (1995) 56(7):330.
   Google Scholar
• DAVANZO P, KRAH N, KLEINER J, MCCRACKEN J: Nimodipine treatment of an adolescent with ultradian cycling bipolar affective illness. J. Child. Adolesc. Psychopharmacol (1999) 9(1):51–61.
   Google Scholar
• MANNA V: Bipolar affective disorders and role of intraneuronal calcium. Therapeutic effects of the treatment with lithium salts and/or calcium antagonist in patients with rapid polar inversion. lVlinerva Med. (1991) 82(11):757–763 [Article in Italian].
   Google Scholar
• PAZZAGLIA P, POST RM, KETTER TA, GEORGE MS, MARANGELL LB: Preliminary controlled trial of nimodipine in ultra-rapid cycling affective dysregulation. Psych. Res. (1993) 49:257–272.
   PubMed Web of Science ®Google Scholar
• PAZZAGLIA P, POST RM, KETTER TA etal.: Nimodipine monotherapy and carbamazepine augmentation in patients 1971 with refractory recurrent affective illness. CM]. Psychopharmacol (1998) 18(5):404–413.
   Google Scholar
• NEMEROFF CB: An ever increasing pharmacopeia for the management of patients with bipolar disorder. j CM]. Psych. (2000) 61\(Suppl. 13):19–23.
   Google Scholar
• CALABRESE JR, MELTZER HY, MARKOVITZ PJ: Clozapine prophylaxis in rapid-cycling bipolar disorder. j Clin. Psychopharmacol (1991) 11:396–397.
   PubMed Web of Science ®Google Scholar
• CALABRESE JR, KIMMEL SE, WOYSHVILLE MJ et al: Clozapine for treatment of refractory mania. Am. j Psych. (1996) 153(6):759–764.
   PubMedGoogle Scholar
• GHAEMI SN, SACHS GS, BALDASSANO C, TRUMAN CJ: Acute treatment of bipolar disorder with adjunctive risperidone in outpatients. Can. Psych. (1997) 42:196–199.
   Google Scholar
• TOHEN M, ZARATE CA, CENTORRINO F, HEGARTY JI, FROESCHL M, ZARATE SB: Risperidone in the treatment of mania. j Clin Psych. (1996) 57:249–253.
   Google Scholar
• BARKIN JS, PAIS VM JR, GAFFNEY MF: Induction of mania by risperidone resistant to mood stabilizers. j Clin. Psychopharmacol (1997) 17(1):57–58.
   Google Scholar
• DWIGHT MM, KECK PE, STANTON SP, STRAKOWSKI SM, MCELROY SL: Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder. Lancet (1994) 344:554–555.
   PubMed Web of Science ®Google Scholar
• ACEVEDO VI, GOODNICK PJ, FREUND B: Risperidone in rapid-cycling bipolar disorder. New Research Program & Abstracts American Psychiatric Association Annual Meeting. Toronto, Ontario, Canada, #NR1 (1998):68.
   Google Scholar
• VIETA E, GASTO C, COLOM MARTINEZ A, OTERO A, VALLEJO J: Treatment of refractory rapid-cycling bipolar disorder with risperidone. j Clin. Psychopharmacol (1998) 18(2):172–174.
   PubMed Web of Science ®Google Scholar
• KETTER TA, WINSBERG ME, DEGOLIA SG, DUNAI M, TATE DL, STRONG CM: Rapid efficacy of olanzapine augmentation in nonpsychotic bipolar mixed states. j CM]. Psych. (1998) 59(2):83–85.
   Google Scholar
• BENAZZI F: Olanzapine-induced psychotic mania in bipolar schizoaffective disorder. Carr. J. Psych. (1999) 44(6):607–608.
   Google Scholar
• FITZ-GERALD MJ, PINKOFSKY HB, BRANNON G, DANDRIGE E, CALHOUN A: Olanzapine-induced mania. Am. J. Psych. (1999) 156(7):1114.
   Google Scholar
• ANANTH J: Is olanzapine a mood stabilizer? Can. j Psych. (1999) 44(9):927–928.
   Google Scholar
• WEISLER RH: Adjunctive use of olanzapine in mood disorders: five case reports. Ann. OM. Psych. (1997) 9:259–262.
   PubMedGoogle Scholar
• MCELROY SL, FRYE M, DENICOFF K etal.: Olanzapine in treatment-resistant bipolar disorder. j Affect. Dis. (1998) 49:119–122.
   PubMedGoogle Scholar
• TOHEN M, BAKER RW, ALTSHULER L etal.: Olanzapine versus divalproex for the treatment of acute mania. ECNPMunich, Germany (2000).
   Google Scholar
• TOHEN M, SANGER TM, MCELROY SL etal.: Olanzapine versus placebo in the treatment of acute mania. Am. j Psych. (1999) 156(5):702–709.
   Google Scholar
• TOHEN M, JACOBS TG, GRUNDY SL et al:Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. Arch. Gen. Psych. (2000) 57:841–849.
   PubMed Web of Science ®Google Scholar
• OOMEN HAPC, SCHIPPERIJIN AJM, DREXHAGE HA: The prevalence of affective disorder and in particular of rapid cycling bipolar disorder in patients with abnormal thyroid function tests. CM]. Endocnnol (1996) 45:215–223.
   Google Scholar
• COWDRY RW, WEHR TA, ZIS AP, GOODWIN FK: Thyroid abnormalities associated with rapid-cycling bipolar illness. Arch. Gen. Psych. (1983) 40(4):414–420.
   Google Scholar
• BAUER MS, WHYBROW PC, WINOKUR A: Rapid cycling bipolar affective disorder. I. Association with grade I hypothyroidism. Arch. Gen. Psych. (1990) 47(5):427–432.
   Google Scholar
• KUSALIC M: Grade II and Grade III hypothyroidism in rapid-cycling bipolar patients. Neuropsychobiology (1992) 25:177–181.
   Google Scholar
• BERRIOS GE, LEYSEN A, SAMUEL C, DOWSON J: Psychiatric morbidity following total and partial thyroidectomy. Acta Psychiatr. Scam/. (1985) 72:369–373.
   Google Scholar
• HERZ M: On rhythmic phenomena in thyroidectomized patients. Acta Psychiatr. Scam/. (1964) 40(Suppl.):449–459.
   Google Scholar
• KLEINER J, ALTSHULER L, HENDRICK V, HERSHMAN JM: Lithium-induced subclinical hypothyroidism: review of the literature and guidelines for treatment. I CM]. Psych. (1999) 60(4):249–255.
   Google Scholar
• VINCENT A, BRAUCH E VINCENT P: Early onset of lithium-associated hypothyroidism. j Psych. NeuroscL (1993) 18:74–77.
   Google Scholar
• WEESTON T, CONSTANTINO J: High dose T4 for rapid cycling bipolar disorder. Am. Acad. Child. Adolesc. Psych. (1996) 35(2):131–132.
   Google Scholar
• EXTEIN IL: High doses of levothyroxine for refractory rapid cycling. Am. I Psych. (2000) 157(10):1704–1705.
   Google Scholar
• STANCER H, PERSAD E: Treatment of intractable rapid-cycling manic-depressive disorder with levothyroxine. Arch. Gen. Psych. (1982) 39(3):311–312.
   PubMedGoogle Scholar
• BAUER MS, WHYBROW PC: Rapid cycling bipolar affective disorder. II. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study. Arch. Gen. Psych. (1990) 47:435–440.
   PubMed Web of Science ®Google Scholar
• BAUMGARTNER A, BAUER M, HELLWEG R: Treatment of intractable non-rapid cycling bipolar affective disorder with high dose thyroxine: an open clinical trial. Neuropsychopharmacology (1994) 10:183–189.
   PubMed Web of Science ®Google Scholar
• AFFLELOU S, AURIACOMBE M, CAZENAVE M, CHARTRES JP, TIGNOL J: Administration of high dose levothyroxine in treatment of rapid cycling bipolar disorders. Lacephale (1997) XXIII:209–217.
   Google Scholar
• HAYKAL RF, AKISKAL H: Bupropion as a promising approach to rapid cycling bipolar II patients. I CM]. Psych. (1990) 51(11):450–455.
   Google Scholar
• BERMAN E, WOLPERT E: Intractable manic-depressive psychosis with rapid-cycling in an 18 year old woman successfully treated with electroconvulsive therapy. I Nerv. Merm Dis. (1985) 175 (4) :236–238.
   Google Scholar
• STOLL AL, SACHS GS, COHEN BM, LAFER B, CHRISTENSEN JD, RENSHAW PF: Choline in the treatment of rapid-cycling bipolar disorder. Biol. Psych. (1996) 40:382–388.
   PubMedGoogle Scholar
• LIEBENLUFT E, TURNER EH, FELDMAN-NAIM S, SCHWARTZ PJ, WEHR TA, ROSENTHAL NE: Light therapy in patients with rapid-cycling bipolar disorder: preliminary results. Psychopharmacol Bull. (1995) 31(4):705–710.
   Google Scholar
• KILZIEH N, AKISKAL H: Rapid cyclingbipolar disorder. Psych. Clin. North Am. (1999) 22(3):585–607.
   Google Scholar
• WEHR TA, TURNER EH, SHIMADA JM, LOWE CH, BARKER C, LEIBENLUFT E: Treatment of a rapidly cycling bipolar patient by using extended bed rest and darkness to stabilize the timing and duration of sleep. Biol. Psych. (1998) 43:822–828.
   PubMed Web of Science ®Google Scholar
• LIEBENLUFT E, ALBERT PS, ROSENTHAL NE, WEHR TA: Relationship between sleep and mood in patients with rapid-cycling bipolar disorder. Psych. Res. (1996) 63:161–168.
   Google Scholar
• SACHS GS, GROSSMAN F, GHEAMI SN, BOWDEN SL: Risperidone plus mood stabilizer versusplacebo plus mood stabilizer for acute mania of bipolar disorder: a double blind comparison of efficacy and safety. 4th International Conference on Bipolar Disorder. Pittsburgh, PA, USA (14–16 June 2001).
   Google Scholar